Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 26, 2017

Friday, March 31, 2017 8:30 am EDT

Dateline:

WALTHAM, Mass.

Public Company Information:

NYSE:
TMO

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter before the market opens on Wednesday, April 26, 2017, and will hold a conference call on the same day at 8:30 a.m. EDT.

During the call, the company will discuss its first quarter financial performance, as well as future expectations. To listen, call (877) 201-0168 within the U.S. or (647) 788-4901 outside the U.S. You may also listen to the call live on the “Investors” section of our website, www.thermofisher.com. The earnings press release and related information can be found in that section of our website under “Financial Results.” A replay of the call will be available under “Webcasts and Presentations” through Friday, May 12, 2017.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Contact:

Thermo Fisher Scientific Inc.
Media Contact Information:
Ron O’Brien, 781-622-1242
ron.obrien@thermofisher.com
Website: www.thermofisher.com
or
Investor Contact Information:
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com

Thermo Fisher Tweets

Introducing the first NGS-based IVD test for detection of genetic mutations in #NSCLC - Oncomine Dx Target Test… https://t.co/jR0BLLcoT0-40 min 41 sec ago
Hi, Can you plz share serial # of your Vanquish system & your location? We can connect you with the right team. Thanks.-4 hours 30 min ago
Scientists will do just about anything to get an automated cell counter! https://t.co/iWeiF2rvuX See the rebellion. https://t.co/8d3TauNecG-5 hours 2 min ago
What’s the advantage of exceptionally bright readouts for better discrimination of cell subpopulations?… https://t.co/0LbS3hM38m-5 hours 2 min ago
We've just received FDA approval for the first NGS-based IVD test for detection of genetic mutations in #NSCLC https://t.co/uXlmLlmTq1-22 hours 46 min ago